In order to monitor your siRNA experiment conditions, Eurogentec provides siRNA control duplexes.
As for any valid experiment, negative and positive controls are necessary.
Positive controls consist of siRNA directed against a range of endogenous and reporter genes. They are available in 5 nmol final quantities. Each control contains 1 siRNA duplex.
All siRNA control duplexes are PAGE purified and 100 % MALDI-TOF Mass Spectrometry controlled.
The sequences are validated and published.
RNA interference is licensed under European Patents 1144623, 1214945 and foreign equivalents from Alnylam Pharmaceuticals, Inc., Cambridge, USA and is provided only for use in academic and commercial research (excluding the evaluation or characterization of this product as the potential basis for a siRNA-based drug) and not for any other commercial purposes. Information about licenses for commercial use (including discovery and development of siRNA-based drugs) is available from Alnylam Pharmaceuticals, Inc., 300 Third Street, Cambridge, MA 02142, USA.